• About us
• Contact

Advertisement

Organisation › Details

Danaher (Group)

Danaher (NYSE:DHR), based in Washington. D.C., is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our portfolio of premier brands is among the most highly recognized in each of the markets we serve. Driven by the Danaher Business System, our 50,000 associates serve customers in more than 125 countries and generated $12.7 billion of revenue in 2008. *

 

	Start	2002-05-06 existent
	Industry	analytical instrument
	Industry 2	diagnostics (medical/biological)
	Person	Blair, Rainer M. (Danaher 2022 CEO before EVP Life Sciences + Head Life Sciences + AB Sciex + Videojet + MAPEI + BASF)
	Person 2	McGrew, Matthew R. (Matt) (Danaher 20901–CFO joined 2012 before KPMG)
	Region	Washington, D.C.
	Country	United States (USA)
	Street	2099 Pennsylvania Avenue, NW
	City	20006 Washington, DC
	Tel	+1-202-828-0850
		Address record changed: 2020-12-02
Basic data	Employees	J: more than 100,0 (2021-12-31)
	Currency	USD
	Annual sales	29,453,000,000 (sales, consolidated (2021) 2021-12-31)
	Profit	6,433,000,000 (2021-12-31)
	Cash	2,586,000,000 (2021-12-31)
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for Danaher (Group)

• [1] Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC....
• [2] Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff....
• [3] Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition"....
• [4] Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin....
• [5] HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA....
• [6] AB Sciex (d/b/a Sciex). (11/1/21). "Press Release: Sciex and Evosep Will Collaborate to Provide Robust, High-throughput Proteomics Workflows"....
• [7] Scitara Corporation. (6/30/21). "Press Release: Scitara Corporation Unleashes Universal Connectivity to Redefine Lab of the Future". Marlborough, MA....
• [8] AB Sciex (d/b/a Sciex). (6/17/21). "Press Release: Sciex OS Introduces New Software with OneOmics Suite and Molecule Profiler App". Framingham, MA....
• [9] Danaher Corporation. (6/17/21). "Press Release: Danaher to Acquire Aldevron". Washington, DC....
• [10] AB Sciex (d/b/a Sciex). (6/17/21). "Press Release: Sciex Presents New Accurate Mass instrument, the ZenoTOF 7600 System". Framingham, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.